Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- JCR, Takeda Wind Up Collab on Gene Therapy Research
December 21, 2023
- Shionogi’s Novel Antibiotic Fetroja Now Available in Japan
December 21, 2023
- Chugai’s Corporate VC Arm to Go Live in 2024
December 20, 2023
- Daiichi Sankyo Launch 2 PIII Breast Cancer Trials for TROP2 ADC
December 20, 2023
- Xocova Rights Sub-Licensed to Juniper in Singapore: Shionogi
December 20, 2023
- Otsuka Bags European Commercial Rights to Ionis’ HAE Drug
December 20, 2023
- Ono, EVQLV Link Arms on AI-Powered Antibody Drug Development
December 20, 2023
- Sanofi Files High-Dose Quadrivalent Flu Vaccine in Japan
December 20, 2023
- DyDo Pharma Files Its 1st Drug, LEMS Treatment for Japan Market
December 19, 2023
- EMA Endorses GHIT-Funded Schistosomiasis Therapy
December 19, 2023
- Dupixent 200 mg Syringe Now Available in Japan: Sanofi
December 19, 2023
- Shionogi, Sobi Ink Fetcroja Distribution Pact for 13 European Countries
December 19, 2023
- Shionogi Kicks Off PIII Booster Trial for XBB1.5 COVID Vaccine in Japan
December 19, 2023
- Takeda’s Hyqvia Gets EU Panel Backing for CIDP Maintenance Therapy
December 19, 2023
- Padcev/Keytruda Combo Nabs FDA Nod for 1st Line Bladder Cancer
December 19, 2023
- Eisai Files Tasurgratinib for Biliary Tract Cancer in Japan
December 19, 2023
- Terumo’s Next CEO Resolved to Drive Biologics Forward, Fulfill Diverse Demands
December 18, 2023
- Eisai CEO Anticipates Leqembi Approval in Europe and China by March
December 18, 2023
- Alecensa Filed for Adjuvant Therapy for ALK-Positive NSCLC: Chugai
December 18, 2023
- Cheplapharm Initiates LLP Acquisitions in Japan, Eyes 10 Asset Takeovers in 2024: Local Head
December 15, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…